Samir Gharib
Director of Finance/CFO presso SPRUCE BIOSCIENCES, INC.
Patrimonio netto: 159 382 $ in data 31/03/2024
Profilo
Samir M.
Gharib is currently the Director at Cancer CAREpoint and the President & Chief Financial Officer at Spruce Biosciences, Inc. Previously, he worked as the Finance Director & Controller at Talon Therapeutics, Inc. from 2011 to 2013, the Managing Director at Benchmark Financial Partners LLC from 2017 to 2018, the Vice President-Finance & Administration at Revance Therapeutics, Inc. from 2013 to 2017, and the Chief Financial Officer at Stemedica Cell Technologies, Inc. from 2018 to 2019.
Mr. Gharib obtained his undergraduate degree from Haas School of Business in 2005 and holds an MBA from the same institution.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
SPRUCE BIOSCIENCES, INC.
0.49% | 25/03/2024 | 202 776 ( 0.49% ) | 159 382 $ | 31/03/2024 |
Posizioni attive di Samir Gharib
| Società | Posizione | Inizio |
|---|---|---|
| SPRUCE BIOSCIENCES, INC. | Director of Finance/CFO | 01/05/2020 |
| Cancer CAREpoint | Director/Board Member | 01/11/2017 |
Precedenti posizioni note di Samir Gharib
| Società | Posizione | Fine |
|---|---|---|
Stemedica Cell Technologies, Inc.
 Stemedica Cell Technologies, Inc. Pharmaceuticals: MajorHealth Technology Stemedica Cell Technologies, Inc. operates as a biotechnology company that manufactures adult allergenic stem cells. Its adult stem cells which are used by research institutions and hospitals for pre-clinical and clinical studies. It has offices in Mexico, Italy, Switzerland, and France. The company was founded by Roger J. Howe and Maynard A. Howe in 2005 and is headquartered in San Diego, CA. | Director of Finance/CFO | 01/09/2019 |
| Benchmark Financial Partners LLC | Corporate Officer/Principal | 01/10/2018 |
| REVANCE THERAPEUTICS, INC. | Chief Administrative Officer | 01/09/2017 |
Talon Therapeutics, Inc.
 Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Comptroller/Controller/Auditor | 01/09/2013 |
Formazione di Samir Gharib
| Haas School of Business | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| REVANCE THERAPEUTICS, INC. | Health Technology |
| SPRUCE BIOSCIENCES, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Talon Therapeutics, Inc.
Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Health Technology |
Stemedica Cell Technologies, Inc.
Stemedica Cell Technologies, Inc. Pharmaceuticals: MajorHealth Technology Stemedica Cell Technologies, Inc. operates as a biotechnology company that manufactures adult allergenic stem cells. Its adult stem cells which are used by research institutions and hospitals for pre-clinical and clinical studies. It has offices in Mexico, Italy, Switzerland, and France. The company was founded by Roger J. Howe and Maynard A. Howe in 2005 and is headquartered in San Diego, CA. | Health Technology |
| Cancer CAREpoint | |
| Benchmark Financial Partners LLC |
- Borsa valori
- Insiders
- Samir Gharib
